Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis

Isoniazid (INH) is a key agent in the treatment of tuberculosis. In Mycobacterium tuberculosis, INH is converted to its active form by KatG, a catalase-peroxidase, and attacks InhA, which is essential for the synthesis of mycolic acids. We sequenced furA-katG and fabG1-inhA in 108 INH-resistant (INH...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular microbiology 2011-03, Vol.79 (6), p.1615-1628
Hauptverfasser: Ando, Hiroki, Kitao, Tomoe, Miyoshi-Akiyama, Tohru, Kato, Seiya, Mori, Toru, Kirikae, Teruo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1628
container_issue 6
container_start_page 1615
container_title Molecular microbiology
container_volume 79
creator Ando, Hiroki
Kitao, Tomoe
Miyoshi-Akiyama, Tohru
Kato, Seiya
Mori, Toru
Kirikae, Teruo
description Isoniazid (INH) is a key agent in the treatment of tuberculosis. In Mycobacterium tuberculosis, INH is converted to its active form by KatG, a catalase-peroxidase, and attacks InhA, which is essential for the synthesis of mycolic acids. We sequenced furA-katG and fabG1-inhA in 108 INH-resistant (INHr) and 51 INH-susceptible (INHs) isolates, and found three mutations in the furA-katG intergenic region (Intg-⁷a, Inta-¹⁰c and Intg-¹²a) in four of 108 INHr isolates (4%), and the furAc⁴¹t mutation with an amino acid substitution in 18 INHr isolates (17%). These mutations were not found in any of 51 INHs isolates tested. We reconstructed these mutations in isogenic strains to determine whether they conferred INH resistance. We found that the Intg-⁷a, Inta-¹⁰c and Intg-¹²a single mutations in the furA-katG intergenic region decreased katG expression and conferred INH resistance. In contrast, the furAc⁴¹t mutation was not sufficient to confer INH resistance. These results suggested that downregulation of katG is a mechanism of INH resistance in M. tuberculosis and that mutations in the furA-katG intergenic region play a role in this resistance mechanism.
doi_str_mv 10.1111/j.1365-2958.2011.07547.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_907160391</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>907160391</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5317-3c18228c2cf40b12babd4b3a8260525bf11cacc8674e899bb74a31f016ea2f5f3</originalsourceid><addsrcrecordid>eNqNkk-PEyEYxonRuN3Vr6DExHiayp9hBg4ezKrrJtt40E28kRcKlTodKsyk7X56GVvXxItygbz8npcHHhDClMxpGa_Xc8obUTEl5JwRSuekFXU73z9As_uNh2hGlCAVl-zrGTrPeU0I5aThj9EZo6yuBacztHoXd31yq7GDIcQeR4-_w3CF3X6bXM5TKWQMOUcbYHBLvAvDt1KKfYC7sMQFCnmA3jocerw42GjADi6FcYOH0bhkxy4W5Al65KHL7ulpvkC3H95_ufxY3Xy6ur58e1PZYqetuKWSMWmZ9TUxlBkwy9pwkKwhggnjKbVgrWza2kmljGlr4NQT2jhgXnh-gV4d-25T_DG6POhNyNZ1HfQujlkr0tKGcEX_SUrRtJJwogr54i9yHcfUl2sUSNZCFWsFkkfIpphzcl5vU9hAOmhK9BSaXuspGz1lo6fQ9K_Q9L5In536j2bjlvfC3ykV4OUJgGyh86m8d8h_OK5qTtrJw5sjtwudO_y3Ab1YXE-ron9-1HuIGlapnHH7mU2_hirBGiX4T8rwvLQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>858459052</pqid></control><display><type>article</type><title>Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis</title><source>MEDLINE</source><source>Wiley Online Library</source><source>Wiley Online Library Free Content</source><source>EZB Electronic Journals Library</source><creator>Ando, Hiroki ; Kitao, Tomoe ; Miyoshi-Akiyama, Tohru ; Kato, Seiya ; Mori, Toru ; Kirikae, Teruo</creator><creatorcontrib>Ando, Hiroki ; Kitao, Tomoe ; Miyoshi-Akiyama, Tohru ; Kato, Seiya ; Mori, Toru ; Kirikae, Teruo</creatorcontrib><description>Isoniazid (INH) is a key agent in the treatment of tuberculosis. In Mycobacterium tuberculosis, INH is converted to its active form by KatG, a catalase-peroxidase, and attacks InhA, which is essential for the synthesis of mycolic acids. We sequenced furA-katG and fabG1-inhA in 108 INH-resistant (INHr) and 51 INH-susceptible (INHs) isolates, and found three mutations in the furA-katG intergenic region (Intg-⁷a, Inta-¹⁰c and Intg-¹²a) in four of 108 INHr isolates (4%), and the furAc⁴¹t mutation with an amino acid substitution in 18 INHr isolates (17%). These mutations were not found in any of 51 INHs isolates tested. We reconstructed these mutations in isogenic strains to determine whether they conferred INH resistance. We found that the Intg-⁷a, Inta-¹⁰c and Intg-¹²a single mutations in the furA-katG intergenic region decreased katG expression and conferred INH resistance. In contrast, the furAc⁴¹t mutation was not sufficient to confer INH resistance. These results suggested that downregulation of katG is a mechanism of INH resistance in M. tuberculosis and that mutations in the furA-katG intergenic region play a role in this resistance mechanism.</description><identifier>ISSN: 0950-382X</identifier><identifier>EISSN: 1365-2958</identifier><identifier>DOI: 10.1111/j.1365-2958.2011.07547.x</identifier><identifier>PMID: 21244531</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Amino acids ; Antitubercular Agents - pharmacology ; Bacteria ; Bacterial Proteins - genetics ; Bacterial Proteins - metabolism ; Bacteriology ; Biological and medical sciences ; Catalase - genetics ; Catalase - metabolism ; Cell Line ; Down-Regulation - drug effects ; Drug resistance ; Drug Resistance, Bacterial ; Fundamental and applied biological sciences. Psychology ; Gene expression ; Gene Expression Regulation, Bacterial - drug effects ; Humans ; Isoniazid - pharmacology ; Microbial Sensitivity Tests ; Microbiology ; Miscellaneous ; Mutation ; Mycobacterium tuberculosis ; Mycobacterium tuberculosis - drug effects ; Mycobacterium tuberculosis - enzymology ; Mycobacterium tuberculosis - genetics ; Protein synthesis ; Tuberculosis ; Tuberculosis - microbiology</subject><ispartof>Molecular microbiology, 2011-03, Vol.79 (6), p.1615-1628</ispartof><rights>2011 Blackwell Publishing Ltd</rights><rights>2015 INIST-CNRS</rights><rights>2011 Blackwell Publishing Ltd.</rights><rights>Copyright Blackwell Publishing Ltd. Mar 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5317-3c18228c2cf40b12babd4b3a8260525bf11cacc8674e899bb74a31f016ea2f5f3</citedby><cites>FETCH-LOGICAL-c5317-3c18228c2cf40b12babd4b3a8260525bf11cacc8674e899bb74a31f016ea2f5f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2958.2011.07547.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2958.2011.07547.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27903,27904,45553,45554,46387,46811</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23943072$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21244531$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ando, Hiroki</creatorcontrib><creatorcontrib>Kitao, Tomoe</creatorcontrib><creatorcontrib>Miyoshi-Akiyama, Tohru</creatorcontrib><creatorcontrib>Kato, Seiya</creatorcontrib><creatorcontrib>Mori, Toru</creatorcontrib><creatorcontrib>Kirikae, Teruo</creatorcontrib><title>Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis</title><title>Molecular microbiology</title><addtitle>Mol Microbiol</addtitle><description>Isoniazid (INH) is a key agent in the treatment of tuberculosis. In Mycobacterium tuberculosis, INH is converted to its active form by KatG, a catalase-peroxidase, and attacks InhA, which is essential for the synthesis of mycolic acids. We sequenced furA-katG and fabG1-inhA in 108 INH-resistant (INHr) and 51 INH-susceptible (INHs) isolates, and found three mutations in the furA-katG intergenic region (Intg-⁷a, Inta-¹⁰c and Intg-¹²a) in four of 108 INHr isolates (4%), and the furAc⁴¹t mutation with an amino acid substitution in 18 INHr isolates (17%). These mutations were not found in any of 51 INHs isolates tested. We reconstructed these mutations in isogenic strains to determine whether they conferred INH resistance. We found that the Intg-⁷a, Inta-¹⁰c and Intg-¹²a single mutations in the furA-katG intergenic region decreased katG expression and conferred INH resistance. In contrast, the furAc⁴¹t mutation was not sufficient to confer INH resistance. These results suggested that downregulation of katG is a mechanism of INH resistance in M. tuberculosis and that mutations in the furA-katG intergenic region play a role in this resistance mechanism.</description><subject>Amino acids</subject><subject>Antitubercular Agents - pharmacology</subject><subject>Bacteria</subject><subject>Bacterial Proteins - genetics</subject><subject>Bacterial Proteins - metabolism</subject><subject>Bacteriology</subject><subject>Biological and medical sciences</subject><subject>Catalase - genetics</subject><subject>Catalase - metabolism</subject><subject>Cell Line</subject><subject>Down-Regulation - drug effects</subject><subject>Drug resistance</subject><subject>Drug Resistance, Bacterial</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene expression</subject><subject>Gene Expression Regulation, Bacterial - drug effects</subject><subject>Humans</subject><subject>Isoniazid - pharmacology</subject><subject>Microbial Sensitivity Tests</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>Mutation</subject><subject>Mycobacterium tuberculosis</subject><subject>Mycobacterium tuberculosis - drug effects</subject><subject>Mycobacterium tuberculosis - enzymology</subject><subject>Mycobacterium tuberculosis - genetics</subject><subject>Protein synthesis</subject><subject>Tuberculosis</subject><subject>Tuberculosis - microbiology</subject><issn>0950-382X</issn><issn>1365-2958</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkk-PEyEYxonRuN3Vr6DExHiayp9hBg4ezKrrJtt40E28kRcKlTodKsyk7X56GVvXxItygbz8npcHHhDClMxpGa_Xc8obUTEl5JwRSuekFXU73z9As_uNh2hGlCAVl-zrGTrPeU0I5aThj9EZo6yuBacztHoXd31yq7GDIcQeR4-_w3CF3X6bXM5TKWQMOUcbYHBLvAvDt1KKfYC7sMQFCnmA3jocerw42GjADi6FcYOH0bhkxy4W5Al65KHL7ulpvkC3H95_ufxY3Xy6ur58e1PZYqetuKWSMWmZ9TUxlBkwy9pwkKwhggnjKbVgrWza2kmljGlr4NQT2jhgXnh-gV4d-25T_DG6POhNyNZ1HfQujlkr0tKGcEX_SUrRtJJwogr54i9yHcfUl2sUSNZCFWsFkkfIpphzcl5vU9hAOmhK9BSaXuspGz1lo6fQ9K_Q9L5In536j2bjlvfC3ykV4OUJgGyh86m8d8h_OK5qTtrJw5sjtwudO_y3Ab1YXE-ron9-1HuIGlapnHH7mU2_hirBGiX4T8rwvLQ</recordid><startdate>201103</startdate><enddate>201103</enddate><creator>Ando, Hiroki</creator><creator>Kitao, Tomoe</creator><creator>Miyoshi-Akiyama, Tohru</creator><creator>Kato, Seiya</creator><creator>Mori, Toru</creator><creator>Kirikae, Teruo</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>201103</creationdate><title>Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis</title><author>Ando, Hiroki ; Kitao, Tomoe ; Miyoshi-Akiyama, Tohru ; Kato, Seiya ; Mori, Toru ; Kirikae, Teruo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5317-3c18228c2cf40b12babd4b3a8260525bf11cacc8674e899bb74a31f016ea2f5f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Amino acids</topic><topic>Antitubercular Agents - pharmacology</topic><topic>Bacteria</topic><topic>Bacterial Proteins - genetics</topic><topic>Bacterial Proteins - metabolism</topic><topic>Bacteriology</topic><topic>Biological and medical sciences</topic><topic>Catalase - genetics</topic><topic>Catalase - metabolism</topic><topic>Cell Line</topic><topic>Down-Regulation - drug effects</topic><topic>Drug resistance</topic><topic>Drug Resistance, Bacterial</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene expression</topic><topic>Gene Expression Regulation, Bacterial - drug effects</topic><topic>Humans</topic><topic>Isoniazid - pharmacology</topic><topic>Microbial Sensitivity Tests</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>Mutation</topic><topic>Mycobacterium tuberculosis</topic><topic>Mycobacterium tuberculosis - drug effects</topic><topic>Mycobacterium tuberculosis - enzymology</topic><topic>Mycobacterium tuberculosis - genetics</topic><topic>Protein synthesis</topic><topic>Tuberculosis</topic><topic>Tuberculosis - microbiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ando, Hiroki</creatorcontrib><creatorcontrib>Kitao, Tomoe</creatorcontrib><creatorcontrib>Miyoshi-Akiyama, Tohru</creatorcontrib><creatorcontrib>Kato, Seiya</creatorcontrib><creatorcontrib>Mori, Toru</creatorcontrib><creatorcontrib>Kirikae, Teruo</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ando, Hiroki</au><au>Kitao, Tomoe</au><au>Miyoshi-Akiyama, Tohru</au><au>Kato, Seiya</au><au>Mori, Toru</au><au>Kirikae, Teruo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis</atitle><jtitle>Molecular microbiology</jtitle><addtitle>Mol Microbiol</addtitle><date>2011-03</date><risdate>2011</risdate><volume>79</volume><issue>6</issue><spage>1615</spage><epage>1628</epage><pages>1615-1628</pages><issn>0950-382X</issn><eissn>1365-2958</eissn><abstract>Isoniazid (INH) is a key agent in the treatment of tuberculosis. In Mycobacterium tuberculosis, INH is converted to its active form by KatG, a catalase-peroxidase, and attacks InhA, which is essential for the synthesis of mycolic acids. We sequenced furA-katG and fabG1-inhA in 108 INH-resistant (INHr) and 51 INH-susceptible (INHs) isolates, and found three mutations in the furA-katG intergenic region (Intg-⁷a, Inta-¹⁰c and Intg-¹²a) in four of 108 INHr isolates (4%), and the furAc⁴¹t mutation with an amino acid substitution in 18 INHr isolates (17%). These mutations were not found in any of 51 INHs isolates tested. We reconstructed these mutations in isogenic strains to determine whether they conferred INH resistance. We found that the Intg-⁷a, Inta-¹⁰c and Intg-¹²a single mutations in the furA-katG intergenic region decreased katG expression and conferred INH resistance. In contrast, the furAc⁴¹t mutation was not sufficient to confer INH resistance. These results suggested that downregulation of katG is a mechanism of INH resistance in M. tuberculosis and that mutations in the furA-katG intergenic region play a role in this resistance mechanism.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>21244531</pmid><doi>10.1111/j.1365-2958.2011.07547.x</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0950-382X
ispartof Molecular microbiology, 2011-03, Vol.79 (6), p.1615-1628
issn 0950-382X
1365-2958
language eng
recordid cdi_proquest_miscellaneous_907160391
source MEDLINE; Wiley Online Library; Wiley Online Library Free Content; EZB Electronic Journals Library
subjects Amino acids
Antitubercular Agents - pharmacology
Bacteria
Bacterial Proteins - genetics
Bacterial Proteins - metabolism
Bacteriology
Biological and medical sciences
Catalase - genetics
Catalase - metabolism
Cell Line
Down-Regulation - drug effects
Drug resistance
Drug Resistance, Bacterial
Fundamental and applied biological sciences. Psychology
Gene expression
Gene Expression Regulation, Bacterial - drug effects
Humans
Isoniazid - pharmacology
Microbial Sensitivity Tests
Microbiology
Miscellaneous
Mutation
Mycobacterium tuberculosis
Mycobacterium tuberculosis - drug effects
Mycobacterium tuberculosis - enzymology
Mycobacterium tuberculosis - genetics
Protein synthesis
Tuberculosis
Tuberculosis - microbiology
title Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T22%3A35%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Downregulation%20of%20katG%20expression%20is%20associated%20with%20isoniazid%20resistance%20in%20Mycobacterium%20tuberculosis&rft.jtitle=Molecular%20microbiology&rft.au=Ando,%20Hiroki&rft.date=2011-03&rft.volume=79&rft.issue=6&rft.spage=1615&rft.epage=1628&rft.pages=1615-1628&rft.issn=0950-382X&rft.eissn=1365-2958&rft_id=info:doi/10.1111/j.1365-2958.2011.07547.x&rft_dat=%3Cproquest_cross%3E907160391%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=858459052&rft_id=info:pmid/21244531&rfr_iscdi=true